I usually try to be nice to drug reps, unless they are really obnoxious, condescending, or try to tie me up when I'm obviously really busy. They're just people trying to do a job (one that I would not want). Some of them are nice and even thank me for my time, and jeez, how often does someone do that? I guess I'm just a sucker for anyone who even fakes respect for me.
I got a visit from the Kapidex rep last week. I mean, I felt bad for the guy even having to TRY and sell this stuff. This is the new R-isomer of Prevacid -- another example of the many 'new' drugs which take an existing drug and tweak it a little to make it sound brand new and different.
You take that existing drug and you market the isomer, prodrug or active metabolite and promote it as the next best thing, especially when the original drug is soon to go generic. And the company offers a discount card for $55 off on Kapidex -- so you know if they are knocking $55 OFF it already costs too much. You look at all the glossy literature and you think, this is an especially unfortunate waste of resources in these tough times. I mean, seriously? I can't wait to see the TV commercials.
The other one out there in the TV commercials now is Oracea, a "unique" formulation (ie. lower dose) of doxycyline, another drug that's been around since the Stone Age. They were even running an ad on my TIVO service. I don't see too much hope for a market share for either of these drugs -- insurances will give them the cold shoulder --- but we'll be forced to stock some eventually and then allow it to expire.
Speaking of old drugs, I'm interested to see if the FDA will pull Darvon and Darvocet-N products. I remember being told in pharmacy school that propoxyphene was a pretty mediocre analgesic with more risks than benefits and I've never been real excited to dispense it to anyone. We've already had a customer panicking on this one.....